M7437

· EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M7437, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors [Phase 1]